Last reviewed · How we verify

NCT04923425

Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy

Completed Last updated 16 June 2021
What this trial tests

trial in Taste Disorders in 30 participants. Completed in 7 October 2020.

Timeline
22 February 2020
Primary endpoint
8 August 2020
7 October 2020

Quick facts

Lead sponsorCairo University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date22 February 2020
Primary completion8 August 2020
Estimated completion7 October 2020
Sites1 location across Egypt

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 50, any sex, with Taste Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Identify possible modulators for developing gustatory dysfunction among a sample of depressed Egyptian adults (age from 20 to 50 years old) under anti-depressants therapy ( for at least 3 months) using a questionnaire ( appendix) with a binary measuring unit (yes/no).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Taste Disorders

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04923425.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing